Our results suggest causal relations between microglial SIRT1 or FOXO1 and therapeutic activity of UB in depression‐related behaviors and/or cytotoxicity and provide more evidence to expand the powerful actions of SIRT1 in the pathology and treatment of depression (Figure 9). This evidence concerns the gene FOXO1 and depressive symptom measurement.